West Pharmaceutical Services Inc (WST) valuation · P/E 50, rev $3.07B
West Pharmaceutical Services Inc (WST) P/E 50, rev $3.07B.
| Metric | Value |
|---|---|
| P/E | 50 |
| Market cap | $15.97B |
| Revenue | $3.07B |
| P/S | 5.2 |
| Dividend yield | 0.38% |
WST valuation FAQ
What is WST's P/E ratio?
West Pharmaceutical Services Inc (WST) trailing P/E is 50 on the latest cached fundamentals snapshot.
What is WST's market cap?
West Pharmaceutical Services Inc (WST) market cap is $15.97B on the latest cached fundamentals snapshot.
What is WST's latest revenue?
Latest cached West Pharmaceutical Services Inc (WST) revenue was $3.07B. Statements: https://lician.com/financials/wst
What is WST's price-to-sales ratio?
West Pharmaceutical Services Inc (WST) price-to-sales (P/S) is 5.2, cached market cap $15.97B divided by revenue $3.07B.
What is WST's dividend yield?
West Pharmaceutical Services Inc (WST) dividend yield is 0.38% on the latest cached fundamentals snapshot.
How many WST valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for West Pharmaceutical Services Inc (WST): P/E, Market cap, Revenue, P/S, and Dividend yield.
Where is WST valuation listed?
Cached valuation multiples for West Pharmaceutical Services Inc (WST) are listed at https://lician.com/valuation/wst.
Not investment advice. Cached rows, not a live tape.